Agilent Technologies, Inc. (NYSE:A) Shares Purchased by Bank of Montreal Can

Bank of Montreal Can boosted its holdings in shares of Agilent Technologies, Inc. (NYSE:A) by 54.8% during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 297,658 shares of the medical research company’s stock after buying an additional 105,336 shares during the quarter. Bank of Montreal Can owned 0.10% of Agilent Technologies worth $44,071,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently added to or reduced their stakes in A. B. Riley Wealth Advisors Inc. raised its stake in shares of Agilent Technologies by 47.9% in the first quarter. B. Riley Wealth Advisors Inc. now owns 5,281 shares of the medical research company’s stock valued at $768,000 after acquiring an additional 1,711 shares in the last quarter. Tidal Investments LLC raised its position in Agilent Technologies by 58.2% in the 1st quarter. Tidal Investments LLC now owns 17,447 shares of the medical research company’s stock valued at $2,540,000 after purchasing an additional 6,420 shares in the last quarter. Swedbank AB purchased a new position in shares of Agilent Technologies in the 1st quarter valued at about $22,588,000. Atria Investments Inc grew its position in shares of Agilent Technologies by 26.6% during the first quarter. Atria Investments Inc now owns 11,841 shares of the medical research company’s stock worth $1,723,000 after buying an additional 2,491 shares in the last quarter. Finally, PGGM Investments increased its stake in shares of Agilent Technologies by 10.9% during the first quarter. PGGM Investments now owns 27,431 shares of the medical research company’s stock worth $3,991,000 after buying an additional 2,699 shares during the period. Hedge funds and other institutional investors own 87.42% of the company’s stock.

Insider Buying and Selling at Agilent Technologies

In other news, SVP Dominique Grau sold 9,990 shares of the company’s stock in a transaction that occurred on Thursday, September 26th. The stock was sold at an average price of $145.00, for a total transaction of $1,448,550.00. Following the completion of the sale, the senior vice president now owns 40,011 shares in the company, valued at $5,801,595. This represents a 19.98 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.33% of the stock is owned by company insiders.

Agilent Technologies Price Performance

Shares of NYSE A opened at $138.14 on Friday. The company has a current ratio of 1.78, a quick ratio of 1.37 and a debt-to-equity ratio of 0.36. Agilent Technologies, Inc. has a twelve month low of $124.10 and a twelve month high of $155.35. The stock has a 50 day moving average of $137.65 and a two-hundred day moving average of $137.44. The stock has a market cap of $39.69 billion, a P/E ratio of 28.66, a P/E/G ratio of 5.91 and a beta of 1.07.

Agilent Technologies Increases Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, January 22nd. Shareholders of record on Tuesday, December 31st will be paid a $0.248 dividend. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $0.99 dividend on an annualized basis and a yield of 0.72%. This is a boost from Agilent Technologies’s previous quarterly dividend of $0.24. Agilent Technologies’s payout ratio is currently 20.54%.

Wall Street Analyst Weigh In

A has been the subject of several analyst reports. Wells Fargo & Company initiated coverage on shares of Agilent Technologies in a report on Tuesday, August 27th. They set an “overweight” rating and a $157.00 price target for the company. TD Cowen increased their target price on Agilent Technologies from $153.00 to $160.00 and gave the company a “buy” rating in a report on Thursday, August 22nd. Sanford C. Bernstein decreased their price target on Agilent Technologies from $140.00 to $135.00 and set a “market perform” rating for the company in a report on Tuesday. UBS Group increased their price objective on Agilent Technologies from $141.00 to $150.00 and gave the company a “neutral” rating in a report on Thursday, August 22nd. Finally, Citigroup boosted their target price on Agilent Technologies from $150.00 to $165.00 and gave the stock a “buy” rating in a research note on Thursday, August 22nd. One investment analyst has rated the stock with a sell rating, seven have assigned a hold rating and eight have issued a buy rating to the stock. According to MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $143.40.

Agilent Technologies Company Profile

Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.